PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF‐κB in esophageal squamous cancer-Reference-Cited by-同舟云学术

PELI1 promotes radiotherapy sensitivity by inhibiting noncanonical NF‐κB in esophageal squamous cancer

Published:2021-11-14 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Dai Dongfang¹²^ORCID,Zhou Hongping³,Yin Li¹,Ye Fei²,Yuan Xiao²,You Tao²,Zhao Xiaohui²,Long Weiguo²,Wang Deqiang²,He Xia¹,Feng Jifeng¹^ORCID,Chen Deyu²

Affiliation:

1. Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research Nanjing China

2. Institute of Oncology Affiliated Hospital of Jiangsu University Zhenjiang China

3. Department of Radiotherapy The Affiliated BenQ Hospital of Nanjing Medical University China

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13134

Reference32 articles.

1. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

2. Oesophageal cancer

3. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial